barre

Ariana Grande’s Powerful Message for the Body-Shamer Who Called Her a Stick

Photo: Getty Images

Photo: Getty Images

Curvy, thin, tall, short—any size seems to be fair game when it comes to body-shaming trolls, as Ariana Grande found out this week. After an Instagram user commented on one of Grande’s photos that they “got asked if I’d prefer @arielwinter1 or @ArianaGrande lol, it wud DEFINITELY be @arielwinter1 curves are sexy sticks aren’t,” Grande responded with an emotional and empowering call for everyone to love who they are.

“Sigh… tweets, comments, statements like this are not okay. About anyone!!! We live in a day and age where people make it IMPOSSIBLE for women, men, anyone to embrace themselves exactly how they are,” she wrote, in an Instagram posted Monday.

Instagram Photo

The singer goes on to add that, “In case you need a reminder, you’re beautiful. It’s beautiful day to be yourself.”

RELATED: Amy Schumer Gets Emotional Talking About Body Image, Empowerment on TODAY

Making this that much sweeter is that Ariel Winters, who stars on the ABC hit Modern Family, quickly tweeted back in support of Grande, thanking her for bringing up the need for body positivity.

This is actually the second time this week that Grande has had to deal with this kind of thing—but thankfully, she is on top of her comeback game.

Grande did an interview with California’s Power 106 FM radio show to promote her new single, “Focus.” But instead of asking her thoughtful questions, DJs Justin Credible and Eric D-Lux defaulted to inane, sexists ones, like which she would choose if she could only use makeup or her cellphone one last time.

“Is this what you think girls have trouble choosing between?” she responded. “Is this men assuming that that’s what girls would have to choose between?”

RELATED: Drew Barrymore Doesn’t Care About Having a Bikini Body: ‘I Am Who I Am’

The men added that men wouldn’t use the new unicorn emoji, and Grande fired back, saying, “You need a little brushing up on equality over here…Who says a unicorn emoji isn’t for men? Come on. I don’t want to hang out at Power 106 anymore.”

Then, later in the interview she responded with this epic takedown when they asked what she’d like to change about the world:

“I have a long list of things I’d like to change. I think just sort of judgement in general; intolerance, meanness, double standards, misogyny, racism, sexism, all that shit. There’s lots we need to get started on, we’ve got work to do!”

She paused, “We’ll start with you, though.

All in all, it looks like Grande really has learned a thing or two since the donut-licking incident.

RELATED: Misty Copeland Gets Candid About Body Image Issues




from Health News / Tips & Trends / Celebrity Health http://ift.tt/1OmIcuq

New Guidelines Focus on Pulmonary Hypertension in Kids

TUESDAY, Nov. 3, 2015 (HealthDay News) — The first guidelines for diagnosis and treatment of pulmonary hypertension in children have been released by the American Heart Association and the American Thoracic Society.

Pulmonary hypertension is a sometimes fatal heart and lung disease that affects nearly two of every 1,000 babies born each year.

Children with the condition have blockages in the blood vessels of their lungs, making it harder for the heart to pump blood through them. Symptoms include shortness of breath, fainting and appearing blue.

“These children suffer with health issues throughout their lives or die prematurely — particularly if they’re not properly diagnosed and managed. But with the proper diagnosis and treatment at a specialized center for pulmonary hypertension, the prognosis for many of these children is excellent,” guidelines committee co-chairman Dr. Stephen Archer said in an American Heart Association news release. Archer is head of medicine at Queens University in Kingston, Ontario, Canada.

Guidelines for diagnosis and treatment of pulmonary hypertension in adults have long been in place. However, they don’t apply to children due to differences in the underlying causes of the disease.

The new guidelines outline how to classify the different types of pulmonary hypertension in children, which is important in determining treatment. They also list approved treatment methods.

The guidelines were published Nov. 3 in the journal Circulation.

“It’s important to note that although these guidelines provide a foundation for taking care of children with pulmonary hypertension, we still have a huge need for more specific data and research to further improve outcomes of children with pulmonary hypertension,” guidelines committee co-chairman Dr. Steven Abman said in the news release. Abman is a pediatric pulmonologist and professor at the University of Colorado School of Medicine and Children’s Hospital in Denver.

Parents often feel hopeless when they learn their child has pulmonary hypertension, but it’s important for them to find doctors and medical centers that handle such cases on a regular basis and offer the latest methods of diagnosis and treatment, Archer said.

More information

The Pulmonary Hypertension Association has more about children with pulmonary hypertension.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/20s3PNM

Childhood Whooping Cough Tied to Small Rise in Epilepsy Risk

TUESDAY, Nov. 3, 2015 (HealthDay News) — Whooping cough may be tied to a slightly increased risk for a young child to develop epilepsy, a new study finds.

Whooping cough (pertussis) is relatively rare in the United States, however. And the absolute risk to any one child of getting epilepsy remains “low,” said Dr. Meghan Fleming, a neurologist at Lenox Hill Hospital in New York City. She reviewed the findings from the new study.

According to background information in the study, vaccination can prevent whooping cough, but roughly 16 million cases of the disease still occur worldwide each year. There were nearly 50,000 whooping cough cases reported in the United States in 2012, the study authors noted.

In the new study, a team led by Dr. Morten Olsen of Aarhus University Hospital in Denmark looked at 4,700 Danish children with whooping cough. The children in the study were born between 1978 and 2011 and were followed until the end of 2011. More than half (53 percent) had been diagnosed with the respiratory infection before they were 6 months old.

Each of the children with whooping cough was compared against 10 age- and gender-matched children in the general population.

While the study couldn’t prove cause-and-effect, Olsen’s team reported that by age 10, epilepsy was diagnosed in 1.7 percent of children in the whooping cough group and 0.9 percent of those in the general population.

The age at which the child had contracted whooping cough seemed to matter. Children older than 3 years old when they were diagnosed with whooping cough were no more likely to develop epilepsy than those in the general population, the study found.

Whooping cough can cause coughing spasms and is associated with seizures in infants, but a link between whooping cough and epilepsy has been unknown, the researchers said.

So what might connect the respiratory ailment and epilepsy? The researchers suggested that brain damage caused by lack of oxygen during coughing fits may be one reason for the possible association.

According to Fleming, “future studies may wish to investigate the underlying immune-linked mechanisms triggered by infections which influence the development of epilepsy.”

The study was published Nov. 3 in the Journal of the American Medical Association.

More information

The American Academy of Family Physicians has more about whooping cough.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/20s3RVF

Multistate Foodborne Illness Outbreaks the Most Deadly: CDC

By Steven Reinberg
HealthDay Reporter

TUESDAY, Nov. 3, 2015 (HealthDay News) — Multistate outbreaks caused by contaminated food account for more than half of all foodborne illness deaths in the United States, even though they only represent 3 percent of all reported outbreaks, a new government report shows.

The findings prompted U.S. health officials to urge the food industry to play a larger role in preventing multistate outbreaks, the U.S. Centers for Disease Control and Prevention said.

“Americans shouldn’t have to worry about getting sick from the food they eat,” CDC director Dr. Tom Frieden said during a news conference Tuesday.

But each year one in six Americans is sickened by contaminated food, he said, adding that, “food industries play a critical role in improving our food safety.”

The food industry can help stop outbreaks by keeping better records to allow officials to trace contaminated food faster and by alerting consumers to recalls, CDC officials said.

Food safety can be improved from farm to table — growing, processing and shipping, Frieden said. The food industry has to meet or exceed new standards under the new U.S. food and Drug Administration’s Food Safety Modernization Act and new U.S. Department of Agriculture regulations, Frieden explained.

The top causes of multistate outbreaks — salmonella, E. coli and listeria — are more dangerous than the leading causes of single-state outbreaks, Frieden said.

These germs cause 91 percent of multistate outbreaks and can be found in contaminated vegetables, beef, chicken and fresh fruits. Because these foods are widely distributed, they can sicken people in many states, the CDC explained.

These outbreaks are more dangerous, because these germs are far more deadly than those that contaminate food in individual kitchens and restaurants, such as norovirus or rotavirus, Frieden said.

“Some of the multistate outbreaks are caused by antibiotic-resistant germs, which can increase the risk of hospitalization and untreatable infections,” Frieden said.

He also pointed out that the number of people sickened in any outbreak are typically greater than those reported. In fact, for every reported case there can be 20 or more unreported cases, Frieden said.

The new report used data from CDC’s Foodborne Disease Outbreak Surveillance System from 2010 to 2014.

Researchers compared the number of illnesses, hospitalizations and deaths from outbreaks in two or more states with those from outbreaks in a single state.

They found that 120 multistate outbreaks caused only 11 percent of all foodborne outbreak illnesses, but they accounted for 34 percent of hospitalizations and 56 percent of deaths. During the five-year study, an average of 24 multistate outbreaks occurred each year, involving anywhere from two to 37 states.

Other highlights from the report include:

  • Salmonella was responsible for the three largest outbreaks, and caused the most illnesses and hospitalizations. The outbreaks were from eggs, chicken and raw ground tuna.
  • Listeria caused the most deaths. These deaths were mostly from an outbreak traced back to contaminated cantaloupe in 2011 that killed 33 people.
  • Imported foods caused 18 of the 120 reported outbreaks. Food from Mexico was the main source in these outbreaks, with food from Turkey pinpointed as the second leading source of imported food outbreaks.

The U.S. Food and Drug Administration is developing new regulations that will require importers to verify that their foods meet U.S. safety standards. In addition, the FDA will hold domestic and foreign companies liable for preventing foodborne illness.

More information

To learn more about food safety, visit the Foodsafety.gov.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1XNjfcU

Study Links Having Children to Lower Ovarian Cancer Risk

TUESDAY, Nov. 3, 2015 (HealthDay News) — The more children a woman has, the lower her risk of ovarian cancer may be, a new study suggests.

The study also found that the risk is lower in women whose fallopian tubes have been tied — a procedure called tubal ligation.

British researchers analyzed data from more than 8,000 women to determine risk factors for the four most common types of ovarian cancer: serous, mucinous, endometrioid and clear cell tumors.

“In the last few years, our understanding of ovarian cancer has been revolutionized by research showing that many cases may not in fact come from the ovaries. For example, many high-grade serous tumors — the most common type — seem to start in the fallopian tubes, while some endometrioid and clear cell tumours may develop from endometriosis,” lead researcher Kezia Gaitskell said in a Cancer Research U.K. news release.

Compared to women with no children, those with one child had a 20 percent lower overall risk of ovarian cancer and a 40 percent lower risk of endometrioid and clear cell tumors. Each additional child offered an additional 8 percent reduction in overall ovarian cancer risk, said Gaitskell, who is a pathologist in the University of Oxford’s Cancer Epidemiology Unit.

Further investigation showed that women whose fallopian tubes had been tied had a 20 percent lower overall risk of ovarian cancer; a 20 percent lower risk for high-grade serous tumors; and a 50 percent lower risk for endometrioid and clear cell tumors.

The study was to be presented Tuesday at a meeting of the U.K.’s National Cancer Research Institute, in Liverpool. Research presented at meetings is typically considered preliminary because it is not subject to the same scrutiny as studies published in medical journals.

It should be noted that the study uncovered a link, but not a cause-and-effect connection, between the number of children a woman has and her risk of ovarian cancer.

The increased risk among women with no children is believed to be related to infertility. Gaitskell noted that some conditions — such as endometriosis — that make it harder for a woman to get pregnant may also increase her risk for specific types of ovarian cancer.

As for the reduced risk among women whose tubes had been tied, Gaitskell said tubal ligation may help prevent abnormal, tumor-causing cells from reaching the ovaries.

“Our results are really interesting, because they show that the associations with known risk factors for ovarian cancer, such as childbirth and fertility, vary between the different tumor types,” she concluded.

Conference Chairman Charlie Swanton, a professor of cancer medicine at the University College London Cancer Institute, said in the news release that the new research expands on existing knowledge.

“We’ve known for some time that the number of children a woman has, and her use of contraception, can influence her risk of ovarian cancer, so this research provides important further detail about different types of the disease,” he said.

Swanton noted that ovarian cancer, like many other cancers, is not one disease, but different diseases that are grouped together because of where they start.

“It’s important to know what affects the risk of different types of ovarian cancer, and what factors impact this. We now need to understand the mechanisms behind these findings to develop some way to extend this lower risk to all women, regardless of how many children they have,” he concluded.

More information

The U.S. Office on Women’s Health has more about ovarian cancer.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1H46RBc

Gonorrhea Becoming More Resistant to One Antibiotic: CDC

By Alan Mozes
HealthDay Reporter

TUESDAY, Nov. 3, 2015 (HealthDay News) — One of several antibiotic treatment options for the sexually transmitted disease gonorrhea seems to be losing its effectiveness, U.S. health officials warn in a new report.

The U.S. Centers for Disease Control and Prevention’s latest tracking suggests that although resistance to the antibiotic treatment cefixime went down between 2011 and 2013, it started to creep back up in 2014.

The good news is that cefixime isn’t usually the first drug of choice for treating gonorrhea infections. The CDC’s most recent guidelines for gonorrhea treatment (issued in 2012) recommend only using cefixime when the preferred option — ceftriaxone-based combination therapy — isn’t available. And the CDC’s new report doesn’t indicate any recent waning in the effectiveness of that combination therapy.

Still, indications of antibiotic resistance among any gonorrhea treatment is considered troubling, the study authors said.

“It is essential to continue monitoring antimicrobial susceptibility and track patterns of resistance among the antibiotics currently used to treat gonorrhea,” said study lead author Dr. Robert Kirkcaldy, an epidemiologist in the CDC’s division of STD prevention in Atlanta.

“Recent increases in cefixime resistance show our work is far from over,” he said.

The study findings are published as a research letter in the Nov. 3 issue of the Journal of the American Medical Association.

The CDC noted that gonorrhea is spread during unprotected vaginal, anal or oral sex. The sexually transmitted infection is particularly common among youth and young adults between the ages of 15 and 24.

Many people have no symptoms when infected. When symptoms do occur, they may include a painful or burning sensation when urinating; painful, swollen testicles and discolored discharge from the penis among men. In women, symptoms may include increased vaginal discharge and vaginal bleeding between periods. Rectal infections may spark soreness, itching, bleeding, discharge, and painful bowel movements, the CDC said.

If gonorrhea goes untreated, “serious health complications” can result, Kirkcaldy said. Those can include chronic pelvic pain, infertility and life-threatening ectopic pregnancy — an abnormal pregnancy that occurs outside of the uterus. In rare cases, gonorrhea can spread to your blood or joints, causing a potentially life-threatening infection, the CDC warned.

But when identified, antibiotics can provide an effective cure for those with gonorrhea.

The new CDC study looked at treatment outcomes among male gonorrhea patients who had been treated at public clinics across the United States between 2006 and 2014.

More than 51,000 samples were gathered across 34 cities. About one-third were collected in the western United States and one-third collected in the South. A little more than a quarter of the samples were drawn from men who either identified as gay or bisexual, the study said.

The investigators found that the CDC’s 2012 shift away from recommending cefixime and toward ceftriaxone-based combination therapy had a profound impact: while the combination therapy had been given to less than 9 percent of the patients in 2006, that figure shot up to nearly 97 percent by 2014.

Alongside that shift, the team found that cefixime-resistance went up from 0.1 percent in 2006 to 1.4 percent in 2011, and then back down to 0.4 percent in 2013. But by 2014 resistance trended upward to 0.8 percent, the research revealed.

What does this mean? “Trends of cefixime susceptibility have historically been a precursor to trends in ceftriaxone,” said Kirkcaldy. “So it’s important to continue monitoring cefixime to be able to anticipate what might happen with other drugs in the future.”

Dr. Kirsten Bibbins-Domingo, co-vice chair of the U.S. Preventive Services Task Force in Rockville, Md., emphasized the importance of routine screening.

“The task force recommends screening for gonorrhea in sexually active women age 24 years or younger, and in older women who are at increased risk for infection,” she said.

The task force doesn’t advocate for or against screening for men, saying more research is needed to prove effectiveness. However, Kirkcaldy said that the “CDC recommends an annual gonorrhea screening for high-risk sexually active women and for sexually active gay, bisexual, and other men who have sex with men.”

More information

There’s more on gonorrhea at the U.S. Centers for Disease Control and Prevention.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1H46Rkz

Prescription Drug Use on the Rise in U.S.

By Steven Reinberg
HealthDay Reporter

TUESDAY, Nov. 3, 2015 (HealthDay News) — More Americans than ever are taking prescription drugs and they’re using more of them, a new study finds.

Fifty-nine percent of adults used prescription drugs in 2011-2012, up from 51 percent in 1999-2000. And 15 percent of them took five or more prescription drugs, an increase from 8 percent in the earlier period, the researchers reported.

Cholesterol-lowering drugs (statins), antidepressants and high blood pressure medications saw especially notable jumps in usage, the study found.

“We wanted to create a comprehensive resource on prescription drug use among U.S. adults, and I think that the implications of these trends vary across classes of drugs,” said lead researcher Elizabeth Kantor, who was with the Harvard School of Public Health in Boston at the time of the study.

Kantor said an increase in one drug class may mean more people are getting treated for a given condition or may reflect a change in the nation’s underlying health needs.

Dr. David Katz, director of the Yale University Prevention Research Center, said the upside to increasing use of modern medications is a decline in the U.S. death rate. Modern medicines are often effective in treating disease and preventing premature death, he said.

“But, of course, not dying isn’t the same as truly living, and that leads to the very ominous implications of this trend,” said Katz, who is also president of the American College of Lifestyle Medicine.

Many drugs are being used to treat avoidable conditions, Katz said.

For the study, published Nov. 3 in the Journal of the American Medical Association, Kantor and her colleagues used data from the National Health and Nutrition Examination Survey to determine trends in prescription drug use among nearly 38,000 adults aged 20 and older between 1999-2000 and 2011-2012. Participants were asked about their prescription drug use in the previous 30 days.

By 2011-2012, the researchers found that:

  • Twenty-seven percent of adults were taking high blood pressure drugs, up from 20 percent a decade earlier.
  • Statin use more than doubled — from 7 percent to 17 percent. The overall prescription drug leader was simvastatin (Zocor), taken by nearly 8 percent of adults. Just 2 percent took it in 1999-2000.
  • Use of antidepressants nearly doubled, increasing from 7 percent to 13 percent.
  • Among 18 types of drugs used by more than 2.5 percent of Americans, use increased for 11 medication types.
  • Significant increases were seen only in people aged 40 and older, not among those 20 to 39.

Increasing use of certain drugs may reflect the growing need to treat conditions associated with overweight and obesity, the researchers said.

Many of the 10 most commonly used drugs in 2010-2011 treat high blood pressure, diabetes and high cholesterol, which are related to diet, exercise and weight, the study authors said. Another drug, omeprazole, is used to treat acid reflux, which can be exacerbated by obesity.

After Zocor, the top 10 included lisinopril (Prinivil), levothyroxine (Levothroid), metoprolol (Lopressor), metformin (Fortamet), hydrochlorothiazide (Aquazide H), omeprazole (Prilosec), amlodipine (Norvasc), atorvastatin (Lipitor), and albuterol (Ventolin, Proventil). Use of all except atorvastatin increased over the study period.

Katz said a healthy lifestyle can prevent most of the chronic diseases these drugs treat, he said.

“Consider the irony. Here in the U.S., we aggressively peddle foods that propagate illness, and drugs to treat the illness that ensues. Big Food and Big Pharma are the winners — we and our families, the losers,” he said.

More information

For advice on healthy living, visit the U.S. Centers for Disease Control and Prevention.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1H46OoS

Extracting Clot Beats Clot-Busting Drug Alone in Study of Stroke Patients

By Dennis Thompson
HealthDay Reporter

TUESDAY, Nov. 3, 2015 (HealthDay News) — Extracting a stroke-causing blood clot is better than just using a clot-busting drug for preserving brain function, a new analysis concludes.

About 45 percent of patients who underwent the clot-removal procedure experienced functional independence at 90 days, compared with about 32 percent of patients treated with the clot-busting IV medication called tissue plasminogen activator (tPA), the researchers found.

The evidence also showed that clot removal is as safe as tPA, said senior study author Dr. Saleh Almenawer, a neurosurgeon at McMaster University in Hamilton, Ontario.

“We didn’t find more deaths, and we didn’t find this therapy to cause more brain bleeds,” Almenawer said.

Stroke victims appeared to have the best chances of all if doctors used an angiogram to locate the offending blood clot, if the latest clot-removal device was used, and if patients were given tPA before clot removal, Almenawer said.

“The combination therapy is perhaps the way to go,” he said. “When stroke patients arrive to the hospital, the protocol should be followed. The IV tPA should be administered, and the angiogram should be performed to locate the blockage.”

The study is published in the Nov. 3 issue of the Journal of the American Medical Association.

Nearly nine out of 10 strokes are caused by a blood clot that blocks one of the arteries supplying blood to the brain, according to the American Heart Association. Standard stroke treatment relies on powerful blood-thinning medications that break up the clot and restore blood flow to the brain.

But when those drugs don’t work, doctors now can turn to a new catheter-based device that will physically remove the blood clot. The tool, called an endovascular stent retrieval device, is made up of wire mesh that resembles a tiny ring of chicken wire.

Skilled surgeons run the device up through a person’s arteries via a catheter, and then open it smack in the middle of a stroke-causing blood clot. They then use the mesh to drag the clot out through the artery.

To compare this device against clot-busting tPA, Almenawer’s team combined data from eight trials involving more than 2,400 stroke patients, including about 1,300 who underwent clot removal and 1,110 who received standard medical care with tPA.

People who had their clots removed via a catheter enjoyed a full recovery more often than those treated with tPA alone, the researchers found.

Both procedures caused a damaging brain bleed about 5 percent of the time, and patients had about the same death rate — 16 percent for those treated with clot removal versus 18 percent for those who received tPA, the findings showed.

The investigators found that patients treated with newer stent retrieval devices had better outcomes than those treated using earlier devices that remove clots using a hook or suction.

“We found the patients who had the stent clot removal had way better outcomes than the patients who had the first-generation device,” Almenawer said.

Dr. Ralph Sacco is chair of neurology at the University of Miami Miller School of Medicine. He pointed out that patients in the study also did better when they first received tPA and, in fact, the more recent clinical trials featured patients who underwent clot removal following tPA therapy.

But for tPA to work effectively, people need to receive the drug within 4.5 hours of suffering their stroke, Sacco added.

“The public needs to know the warning signs of stroke and call 911 immediately, since time delays are still the major factor limiting the number of patients who can benefit from these devices,” according to Sacco, who was not involved with the new report.

The device is more expensive to use than the IV drug, Almenawer said, but it’s likely to save money in the long run by preventing long-term disability in stroke victims.

“If you look at the amount of money spent on the hospitalization, it’s way, way more than the money spent on that small device,” Almenawer said. “And I’m talking about the difference between people who leave the hospital normal versus people who leave the hospital in a wheelchair.”

More information

For more about stroke, visit the U.S. National Institutes of Health.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1H46O8k

Anti-Smoking Programs May Sometimes Backfire

TUESDAY, Nov. 3, 2015 (HealthDay News) — Programs that stigmatize smoking can backfire.

That’s the conclusion of new research that found that, while portraying smoking as socially unacceptable can persuade some smokers to quit, it can make others angry and defensive and harm their self-esteem, making it harder to quit.

To reach that conclusion, the researchers reviewed nearly 600 studies. In one study, 27 percent of smokers felt they were treated differently due to their smoking. In another, between 30 percent and 40 percent of smokers reported experiencing high levels of family disapproval and social rejection. Yet another study found that 39 percent of smokers believed people thought less of them.

In many studies, smokers used words such as “leper,” “outcast,” “bad person,” “low-life” and “pathetic” to describe how negative public health messages about smoking made them feel.

For some smokers, such stigmatization led to increased resistance to quitting, a return to smoking after quitting, increased stress and self-imposed social isolation.

“The stereotypes that smokers deal with are almost universally negative,” study co-author Sara Evans-Lacko said in a Pennsylvania State University news release.

“The stigma for parents who smoke is particularly strong,” added Evans-Lacko, a research fellow at the London School of Economics and Political Science in England.

The findings show that while negative messages can persuade some smokers to quit, anti-smoking programs should also use positive approaches, such as highlighting the benefits of quitting, the researchers said.

“Future research is needed to understand what factors are related to how individuals respond to smoking stigma,” study co-author Rebecca Evans-Polce said in the news release. Evans-Polec is a postdoctoral fellow in Penn State’s Methodology Center and the Bennett Pierce Prevention Research Center.

The study findings were published Nov. 2 in the journal Social Science & Medicine.

More information

The American Cancer Society offers a guide to quitting smoking.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1H46QgC

Anti-Smoking Programs May Sometimes Backfire

TUESDAY, Nov. 3, 2015 (HealthDay News) — Programs that stigmatize smoking can backfire.

That’s the conclusion of new research that found that, while portraying smoking as socially unacceptable can persuade some smokers to quit, it can make others angry and defensive and harm their self-esteem, making it harder to quit.

To reach that conclusion, the researchers reviewed nearly 600 studies. In one study, 27 percent of smokers felt they were treated differently due to their smoking. In another, between 30 percent and 40 percent of smokers reported experiencing high levels of family disapproval and social rejection. Yet another study found that 39 percent of smokers believed people thought less of them.

In many studies, smokers used words such as “leper,” “outcast,” “bad person,” “low-life” and “pathetic” to describe how negative public health messages about smoking made them feel.

For some smokers, such stigmatization led to increased resistance to quitting, a return to smoking after quitting, increased stress and self-imposed social isolation.

“The stereotypes that smokers deal with are almost universally negative,” study co-author Sara Evans-Lacko said in a Pennsylvania State University news release.

“The stigma for parents who smoke is particularly strong,” added Evans-Lacko, a research fellow at the London School of Economics and Political Science in England.

The findings show that while negative messages can persuade some smokers to quit, anti-smoking programs should also use positive approaches, such as highlighting the benefits of quitting, the researchers said.

“Future research is needed to understand what factors are related to how individuals respond to smoking stigma,” study co-author Rebecca Evans-Polce said in the news release. Evans-Polec is a postdoctoral fellow in Penn State’s Methodology Center and the Bennett Pierce Prevention Research Center.

The study findings were published Nov. 2 in the journal Social Science & Medicine.

More information

The American Cancer Society offers a guide to quitting smoking.





from Health News / Tips & Trends / Celebrity Health http://ift.tt/1KWmtl8